RNA immunoprecipitation and proteasome inhibition assays demonstrated this mechanism, while in vivo models using C57BL/6 mice showed that silencing circRHBDD1 reduced tumor growth by enhancing CD8+ T cell responses, underscoring the critical involvement of IMP2 in the immune evasion strategies of gastric cancer. The gene discussed is IGF2BP2; the disease is gastric cancer.